Nijhawan Pardeep 4

4 · Edesa Biotech, Inc. · Filed Feb 2, 2026

AI-generated summary of this filing

Updated Feb 2, 2026

Edesa Biotech (EDSA) CEO Pardeep Nijhawan Receives Award

What Happened

Pardeep Nijhawan, CEO of Edesa Biotech (EDSA), was granted 11,168 restricted share units (RSUs) on 2026-02-02. The RSUs vested in full upon grant and were reported as acquired at $0.00, resulting in no cash payment by the reporting person.
Transaction type: Award/Grant (code A). Reported acquisition value: $0.

Key Details

Transaction date: 2026-02-02; Price per share reported: $0.00; Shares acquired: 11,168 RSUs.
Filing date/accession: Report filed 2026-02-02 (appears timely; no late filing indicated).
Shares owned after transaction: Not specified in the provided filing excerpt.
Footnotes of note:
- F1: These were RSUs granted under the Issuer's 2019 Equity Incentive Compensation Plan and vested in full upon grant.
- F2 & F3: Some reported shares are held by entities/trusts wholly owned or co-trusteed by the reporting person; Nijhawan disclaims beneficial ownership except to the extent of his pecuniary interest.

Context

RSU grants that vest immediately are a form of compensation, not an open-market purchase or sale, and do not necessarily indicate the insider is buying or selling based on company outlook.
The disclaimers about entity/trust ownership mean some shares appear in this filing for reporting purposes but may be owned by related entities; that does not change the nature of the award.

Form 4

Period: 2026-02-02

DirectorChief Executive Officer10% Owner

Transactions

Holdings

Common Shares
[F2]
(indirect: Held by Pardeep Nijhawan Medicine Professional Corporation)
341,702
Common Shares
[F3]
(indirect: By Trust)
32,609
Common Shares
[F2]
(indirect: Held by The Digestive Health Clinic Inc.)
32,013
Common Shares
[F2]
(indirect: Held by 1968160 Ontario Inc.)
53,104

Footnotes (3)

[F1]Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
[F2]Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F3]Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Signature

/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan|2026-02-02

1 file